Detalhe da pesquisa
1.
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.
N Engl J Med;
378(18): 1671-1680, 2018 May 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29668352
2.
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med;
201(12): 1508-1516, 2020 06 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32162970
3.
A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids.
Respir Res;
21(1): 148, 2020 Jun 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32532275
4.
Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.
N Engl J Med;
374(19): 1822-30, 2016 May 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26949137
5.
Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma.
N Engl J Med;
375(9): 840-9, 2016 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27579634
6.
Circulating neutrophils levels are a predictor of pneumonia risk in chronic obstructive pulmonary disease.
Respir Res;
20(1): 195, 2019 Aug 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31443653
7.
Reliability, validity and responsiveness of E-RS:COPD in patients with spirometric asthma-COPD overlap.
Respir Res;
20(1): 107, 2019 May 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31151458
8.
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med;
196(4): 438-446, 2017 08 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28375647
9.
Clinical Course and Management of Hypertrophic Cardiomyopathy.
N Engl J Med;
379(20): 1976-7, 2018 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30440115
10.
A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol.
Eur Respir J;
48(2): 320-30, 2016 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27418551
11.
No dose effect observed with chronic fluticasone propionate on growth velocity in children.
Pediatr Allergy Immunol;
32(2): 377-381, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32966707
12.
Dose-response modelling of umeclidinium and fluticasone furoate/umeclidinium in asthma.
Eur J Clin Pharmacol;
71(9): 1051-8, 2015 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26174114
13.
Salmeterol and Fluticasone Propionate in Children with Asthma.
N Engl J Med;
375(22): e46, 2016 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27959746
14.
Safety Study of Salmeterol in Asthma in Adults.
N Engl J Med;
375(11): 1098, 2016 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27626531
15.
The Significance of Eosinophilic Inflammation in Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med;
197(7): 967-968, 2018 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29140724
16.
Reply to Suissa and Ariel: The FULFIL Trial.
Am J Respir Crit Care Med;
197(4): 542-543, 2018 02 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28950068
17.
Reply to Morice and Hart: Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med;
197(9): 1230-1231, 2018 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29241016
18.
Reply: "FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease" and "Triple Therapy in Chronic Obstructive Pulmonary Disease".
Am J Respir Crit Care Med;
196(8): 1083-1084, 2017 10 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28534669
19.
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
Lancet Respir Med;
9(1): 69-84, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32918892
20.
Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study.
Adv Ther;
37(9): 3775-3790, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32647911